DTC genetic testing companies fail transparency prescriptions

New Genetics and Society

Volumn 30, Issue 4, 2011, Pages 291-307

  Lewis, Norman P ^a   Treise, Debbie ^a   Hsu, Stephen I ^b   Allen, William L ^b   Kang, Hannah ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

direct to consumer; ethics; genetic testing

Indexed keywords

DNA;

CERTIFICATION; GENETIC COUNSELING; GENETIC PRIVACY; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HEALTH CARE INDUSTRY; HEALTH CARE POLICY; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MEDICOLEGAL ASPECT; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84857535084     PISSN: 14636778     EISSN: 14699915     Source Type: Journal    
DOI: 10.1080/14636778.2011.600434     Document Type: Review

References (61)

1. Adeyemo, A. and Rotimi, C., 2010. Genetic variants associated with complex human diseases show wide variation across multiple populations. Public Health Genomics, 13, 72-79.
2. Alpert, S., 2008. Privacy issues in clinical genomic medicine, or Marcus Welby, M.D., meets the 1000 genome. Cambridge Quarterly of Healthcare Ethics, 17, 373-384.
3. Altshuler, D. and Daly, M., 2007. Guilt beyond a reasonable doubt. Nature Genetics, 39 (7), 813-815.
4. American College of Medicine Genetics, 2004. ACMG statement on direct-to-consumer genetic testing. Genetics in Medicine, 6 (1), 60
5. American College of Obstetricians and Gynecologists, 2008. Direct-to-consumer marketing of genetic testing. Obstetrics & Gynecology,111 ( 6), 1493-1494
6. Angrist, M., 2010. Here is a human being: at the dawn of personal genomics. New York: HarperCollins.
7. Beauchamp, T.L. and Childress, J.F., 2009. Principles of biomedical ethics. 6th ed. New York: Oxford University Press.
8. Bennis, W., Goleman, D., and O'toole, J., 2008. Transparency: how leaders create a culture of candor. San Francisco: Jossey-Bass.
9. Berenson, R.A. and Cassel, C.K., 2009. Consumer-driven health care may not be what patients need - caveat emptor. Journal of the American Medical Association, 301 (3), 321-323.
10. Berg, C. and Fryer-Edwards, K., 2007. The ethical challenges of direct-to-consumer genetic testing. Journal of Business Ethics, 77, 17-31.
11. Burke, W. and Psaty, B.M., 2007. Personalized medicine in the era of genomics. Journal of the American Medical Association, 298 (14), 1682-1684.
12. Burke, W., Laberge, A.-M., and Press, N., 2010. Debating clinical utility. Public Health Genomics, 13, 215-223.
13. Cameron, L.D., et al., 2009. Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychology, 28 (3), 307-316.
14. Caulfield, T., 2009. Direct-to-consumer genetics and health policy: a worst-case scenario? American Journal of Bioethics, 9 (6-7), 48-50.
15. Collins, F.S., 2010. The language of life. New York: HarperCollins.
16. Darcé, K., 2010. Genetics test sellers come under fire. San Diego Union-Tribune, 23 July, p. A1.
17. Davies, K., 2010. The 1,000 genome. New York: Free Press.
18. Department of Health and Human Services, 2008. US System of oversight of genetic testing: a response to the charge of the Secretary of Health and Human Services. Report of the Secretary's Advisory Committee on Genetics, Health, and Society. Washington: Department of Health and Human Services [online]. Available from: http://oba.od.nih.gov/oba/SACGHS/reports/SACGHS-oversight-report.pdf [Accessed 10 November 2010].
19. GINA: The Genetic Information Nondiscrimination Act of 2008: Information for Researchers and Health Care Professionals 2009 Department of Health and Human Services Washington: Department of Health and Human Services [online]. Available from: Accessed 11 November http://www.genome.gov/Pages/PolicyEthics/ GeneticDiscrimination/GINAInfoDoc.pdf.
20. Duke, J., Friedlin, J., and Ryan, P., 2011. A quantitative analysis of adverse events and "overwarning" in drug labeling. Archives of Internal Medicine, 171 (10), 944-946.
21. Einsiedel, E.F. and Geransar, R., 2009. Framing genetic risk: trust and credibility markers in online direct-to-consumer advertising for genetic testing. New Genetics and Society, 28 (4), 339-362.
22. Evans, J.P. and Green, R.C., 2009. Direct to consumer genetic testing: avoiding a culture war. Genetics in Medicine, 11 (8), 568-569.
23. Farkas, D.H. and Holland, C.A., 2009. Direct-to-consumer genetic testing: two sides of the coin. Journal of Molecular Diagnostics, 1 (4), 263-265.
24. Fung, A., Graham, M., and Weil, D., 2007. Full disclosure: the perils and promise of transparency. New York: Cambridge University Press.
25. Genetics & Public Policy Center 2010. Updated chart of direct-to-consumer genetic testing companies available, 28 May [online]. Available from http://www.dnapolicy.org/news.release. php?action= detail&pressrelease-id=137 [Accessed 30 October 2010].
26. Geransar, R. and Einsiedel, E., 2008. Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware? Genetic Testing, 12 (1), 13-23.
27. Goddard, K.A.B., et al., 2008. Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis. Public Health Genomics, 12, 92-104.
28. Gollust, S.E., Hull, S.C., and Wilfond, B.S., 2002. Limitations of direct-to-consumer advertising for clinical genetic testing. Journal of American Medical Association, 288 (14), 1762-1767.
29. Gollust, S.E.,Wilfond, B.S., and Hull, S.C., 2003. Direct-to-consumer sales of genetic services on the Internet. Genetics in Medicine, 5 (4), 332-337.
30. Gravlee, C.C., Non, A.L., and Mulligan, C.J., 2009. Genetic ancestry, social classification, and racial inequalities in blood pressure in Southeastern Puerto Rico. PLoS One, 4 (9), e6821 [online]. Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone. 0006821 [Accessed 15 December 2010].
31. Henderson, M., 2010. Cashing in on your genes. The Times, 7 January, pp. 26-29.
32. Hogarth, S., 2010. Myths, misconceptions and myopia: searching for clarity in the debate about the regulation of consumer genetics. Public Health Genomics, 13, 322-326.
33. Hudson, K., et al., 2007. ASHG statement on direct-to-consumer genetic testing in the United States. American Journal of Human Genetics, 81, 635-637.
34. Hunter, D.J., Khoury, M.J., and Drazen, J.M., 2008. Letting the genome out of the bottle - will we get our wish? New England Journal of Medicine, 358 (2), 105-107.
35. Janssens, A.C.J.W., et al., 2008. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. American Journal of Human Genetics, 82, 593-599.
36. Javitt, G.H., 2006. Public implications of genetic testing: not just for geneticists anymore. Advances in Chronic Kidney Disease, 13 (2), 178-182.
37. Jordens, C.F.C., Kerridge, I.H., and Samuel, G.N., 2009. Direct-to-consumer personal genome testing: the problem is not ignorance - it is market failure. American Journal of Bioethics, 9 (6-7), 13-15.
38. Kraft, P. and Hunter, D.J., 2009. Genetic risk prediction - are we there yet? New England Journal of Medicine, 360, 1701-1703.
39. Kutz, G., 2006. Nutrigenetic testing. Testimony before the US Senate Special Committee on Aging. US Government Accountability Office, 27 July [online]. Available from http://www.gao.gov/new.items/d06977t.pdf [Accessed 30 October 2010].
40. Kutz, G., 2010. Direct-to-consumer genetic tests. Testimony before the House Energy and Commerce subcommittee on oversight and investigations. US Government Accountability Office, 22 July [online]. Available from http://energycommerce.house.gov/documents/20100722/Kutz. Testimony.07.22.2010. pdf [Accessed 20 October 2010].
41. Lewis, R., 2010. Human genetics: concepts and applications. 9th ed. New York: McGraw-Hill.
42. Liu, Y. and Pearson, Y.E., 2008. Direct-to-consumer marketing of predictive medicine genetic tests: assessment of current practices and policy recommendations. Journal of Public Policy & Marketing, 27 (2), 131-148.
43. Lowery, J.T., et al., 2008. The impact of direct-to-consumer marketing of cancer genetic testing on women according to their genetic risk. Genetics in Medicine, 10 (12), 888-894.
44. Magnus, D., Cho, M.K., and Cook-Deegan, R., 2009. Direct-to-consumer tests: beyond medical regulation? Genome Medicine, 1 (2), 17.1-17.3.
45. Manolio, T.A., 2010. Genomewide association studies and assessment of the risk of disease. New England Journal of Medicine, 363, 166-176.
46. McGuire, A.L. and Burke, W., 2008. An unwelcome side effect of direct-to-consumer personalgenome testing. Journal of the American Medical Association, 300 (22), 2669-2671.
47. Morgan, M., 2010. FDA warns companies about direct-to-consumer genetics tests. Neurology Today, 5 August, p. 28.
48. Mykitiuk, R., 2004. Caveat emptor: direct-to-consumer supply and advertising of genetic testing. Clinical and Investigative Medicine, 27 (1), 23-32.
49. Ng, P.C., et al., 2009. An agenda for personalized medicine. Nature, 461 (7265), 724-736.
50. Oliver, R.W., 2004. What is transparency? New York: McGraw-Hill.
51. Pollack, A., 2010a. Outlook uncertain. New York Times, 20 March, p. B1.
52. Pollack, A., 2010b. FDA faults companies on unapproved genetic tests. New York Times, 11 June, p. B2.
53. Ricketts, C., 24 August 2009. Complete Genomics seals $45M for cheaper gene sequencing. Venture Beat [online]. Available from: http://venturebeat.com/2009/08/24/complete-genomics-seals- 45m-for-cheaper-gene- sequencing/[Accessed 12 November 2010].
54. Reilly, P.R., Boshar, M.F., and Holtzman, S.H., 1997. Ethical issues in genetic research: disclosure and informed consent. Nature Genetics, 15, 16-20.
55. Schwartz, P.H., 2009. The value of information and the ethics of personal-genomic screening. American Journal of Bioethics, 9 (4), 26-27.
56. Scott, J. (jscott22@jdh.edu), 16 June 2010. Re: DTC company chart. Email to N. Lewis (nlewis@jou.ufl.edu).
57. Tamir, S., 2010. Direct-to-consumer genetic testing: ethical-legal perspectives and practical considerations. Medical Law Review, 18, 213-238.
58. Vorhaus, D., 21 July 2010. While you were meeting: FDA mails letters to 14 more genetic test providers. Genomics Law Report [online]. Available from: http://www.genomicslawreport. com/index.php/2010/07/21/14-more-fda-letters/ [Accessed 12 November 2010].
59. Wasson, K., 2009. Direct-to-consumer genomics and research ethics: should a more robust informedconsent process be included? American Journal of Bioethics, 9 (6-7), 56-58.
60. Williams, R., 2010. Genomics in our own hands. The Lancet Neurology, 9, 656-657.
61. Williams-Jones, B., 2003. Where there's a Web, there's a way: commercial genetic testing and the Internet. Community Genetics, 6, 46-57.